Chairperson: Iqbal S. Grewal Ph.D., FRCPath., Vice President, Preclinical Therapeutics, Seattle Genetics, Inc.

Targeting CD70 
Iqbal S. Grewal Ph.D., FRCPath., Vice President, Preclinical Therapeutics, Seattle Genetics, Inc.

Pre-clinical studies of anti-OX40L in TH2-driven diseases
Sarah Hymowitz, Ph.D., Scientist, Protein Engineering, Genentech

TWEAKing Inflammatory Disease by a Multifunctional Cytokine
Linda Burkly, Ph.D., Distinguished Investigator, Immunology, Biogen Idec

TBD (BAFF)
Professor Fabienne Mackay Ph.D., Director, Autoimmunity Research Unit, Wellcome Trust Senior Research Fellow, Garvan Institute of Medical Research

Talk Title to Be Determined
Sanjay Khare, Ph.D., Sr. Principal Scientist, Inflammation Research, Amgen 

Chairperson: Thomas Hamilton, Ph.D., Chairman, Department of Immunology, Lerner Research Institute, Cleveland Clinic; Editor-in-Chief, Journal of Interferon & Cytokine Research 

Post-Transcriptional Controls of Cytokine Expression 
Thomas Hamilton, Ph.D., Chairman, Department of Immunology, Lerner Research Institute, Cleveland Clinic; Editor-in-Chief, Journal of Interferon & Cytokine Research 

Regulation and Function of Inflammatory TH17 Cells 
Chen Dong, Ph.D., Associate Professor, Department of Immunology, MD Anderson Cancer Center

SIGIRR, a Negative Regulator for TLR-IL-1R Signaling
Xiaoxia Li, Ph.D., Department of Immunology, Lerner Research Institute, Cleveland Clinic

Chairperson: Ziwei Huang, Ph.D., Professor, The Burnham Institute for Medical Research, Professor of Pathology, School of Medicine, University of California at San Diego

Mechanism of Recognition and Signaling in Chemokine Receptors: Implications for AIDS, Cancer, Immune Diseases and Stem Cell-based Therapies
Ziwei Huang, Ph.D., Professor, The Burnham Institute for Medical Research, Professor of Pathology, School of Medicine, University of California at San Diego

Vicriviroc: A Small Molecule CCR5 Antagonist for HIV
Schering-Plough Research Institute (tentative) 

Targeting CCR9: A Novel Approach to the Treatment of Inflammatory Bowel Disorders 
Matthew Walters, Ph.D., Scientist, Biology, ChemoCentryx 

Mozobil: A CXCR4 Antagonist for Hematopoietic Stem Cell Mobilization
Simon Fricker, Ph.D., Director, Biology, AnorMED Inc.

Protein Structural Modeling and Design to Develop Cytokine-targeted Immunotherapeutics
Sameer Kawatkar, Ph.D., Senior Scientist, Drug Discovery, Chemokine Pharmaceuticals Inc.

IL-22, a Cytokine Made by Th17 Cells, Regulates Local Inflammation 
Lynette Fouser, Ph.D., Principle Research Scientist II, Discovery Research 丒Inflammation, Wyeth 

TBD (CXCR2)
William Hipkin, Ph.D., Senior Principal Scientist, Department of Inflammation, Schering-Plough Research Institute

IL-6 in Inflammatory Disease and Cancer
Bailin Liang, Ph.D., Senior Research Scientist, Immunobiology, Centocor

Talk Title to Be Determined
Sanjay Khare, Ph.D., Sr. Principal Scientist, Inflammation Research, Amgen